Larry and Bohsie were 'published' articles, not just MB blog postings. Other than them there has been 1 positive 'published analysis' linked to here but that's no more credible imo.
Of COURSE NWBO can't do any off the fly kind of analysis of their own, based on enrollment date or otherwise 'sell' the trial results in advance! Frankly I find Leprecon to be the most credible wrt that analysis, but in any case it's frankly insane to expect somebody running a trial to do any kind of analysis like this ahead of reporting actual trial results. That could really get them on the wrong side of the FDA, the last thing they'd want.
Market Data 
Markets 
AI
